Skip to content

RayStation 6.2

by RaySearch Laboratories AB (PUBL)

RayStation 6.2 is a radiation therapy software (FDA Class II; FDA product code MUJ, System, Planning, Radiation Therapy Treatment) made by RaySearch Laboratories AB (PUBL), cleared under FDA 510(k) K171536 on 27 Jun 2017 and listed in FDA GUDID since 2 May 2018 (UDI-DI 07350002010075), active as of 23 Oct 2026. 6 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

510(k) K171536

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07350002010075 UDI-DI Date2 May 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK171536 Date27 Jun 2017DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K171536 decided 27 Jun 2017 Active
  • FDA GUDID UDI-DI 07350002010075 listed 2 May 2018 Listed

Recalls

6 recalls · 2 ongoing · FDA

    • Ongoing Z-2494-2025 FDA Class II initiated 8 Aug 2025

    DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.

    • Ongoing Z-1192-2025 FDA Class II initiated 16 Jan 2025

    Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.

    • Terminated Z-2290-2018 FDA Class II initiated 28 Mar 2018

    The dose calculation accuracy may in some situations be less than expected. The user must be aware in order to avoid incorrect dose calculations during treatment planning.

    • Terminated Z-1275-2018 FDA Class II initiated 26 Jan 2018

    Software issue with Center Beam in Field functionality. Issue can result in incorrect treatment volume delivered to patient.

    • Terminated Z-1930-2019 FDA Class II initiated 20 Nov 2017

    When calculating electron Monte Carlo dose with a very large number of histories, the dose calculation may be wrong

    • Terminated Z-0380-2018 FDA Class II initiated 17 Jul 2017

    For the proton QA preparation module in RayStation 6 (including SP1 and SP2), if the snout position or gap is modified in the QA module, the dose in the QA module may be computed for a different setup than what is used for QA measurements. This could result in an incorrect dosage being provided to a patient.

Timeline

8 dated events

  1. Cleared FDA 510(k) K171536
  2. Recall initiated FDA recalls Z-0380-2018
  3. Recall initiated FDA recalls Z-1930-2019
  4. Recall initiated FDA recalls Z-1275-2018
  5. Recall initiated FDA recalls Z-2290-2018
  6. Listed FDA GUDID 07350002010075
  7. Recall initiated FDA recalls Z-1192-2025
  8. Recall initiated FDA recalls Z-2494-2025

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
RayStation
Generic name
Radiation therapy software
Model / reference
6.2
Primary DI / UDI-DI
07350002010075
510(k) Number
FDA product code
MUJ
GMDN term
Radiation therapy software
Device class
Class II
Regulation number
892.5050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Radiation therapy software.

Other devices from RaySearch Laboratories AB (PUBL)

See all devices from RaySearch Laboratories AB (PUBL) →

Properties

  • Prescription use
  • Manufacturing date
Other properties (13, all answered No)